OCCD test result . | All (n = 3223) . | Year 1 (n = 1478) . | Year 2 (n = 1745) . | Significance (P) . |
---|---|---|---|---|
TFF3 negative | 1031 (32.0%) | 398 (26.9%) | 633 (36.3%) | <0.001 |
TFF3 positive | 1598 (49.6%) | 775 (52.5%) | 823 (47.2%) | 0.003 |
Atypia | 151 (4.7%) | 98 (6.6%) | 53 (3.0%) | <0.001 |
P53 | 120 (3.7%) | 80 (5.4%) | 40 (2.3%) | <0.001 |
Insufficient | 323 (10.0%) | 127 (8.6%) | 196 (11.2%) | 0.013 |
OCCD test result . | All (n = 3223) . | Year 1 (n = 1478) . | Year 2 (n = 1745) . | Significance (P) . |
---|---|---|---|---|
TFF3 negative | 1031 (32.0%) | 398 (26.9%) | 633 (36.3%) | <0.001 |
TFF3 positive | 1598 (49.6%) | 775 (52.5%) | 823 (47.2%) | 0.003 |
Atypia | 151 (4.7%) | 98 (6.6%) | 53 (3.0%) | <0.001 |
P53 | 120 (3.7%) | 80 (5.4%) | 40 (2.3%) | <0.001 |
Insufficient | 323 (10.0%) | 127 (8.6%) | 196 (11.2%) | 0.013 |
OCCD, esophageal cell collection device; TFF3, trefoil factor 3.
OCCD test result . | All (n = 3223) . | Year 1 (n = 1478) . | Year 2 (n = 1745) . | Significance (P) . |
---|---|---|---|---|
TFF3 negative | 1031 (32.0%) | 398 (26.9%) | 633 (36.3%) | <0.001 |
TFF3 positive | 1598 (49.6%) | 775 (52.5%) | 823 (47.2%) | 0.003 |
Atypia | 151 (4.7%) | 98 (6.6%) | 53 (3.0%) | <0.001 |
P53 | 120 (3.7%) | 80 (5.4%) | 40 (2.3%) | <0.001 |
Insufficient | 323 (10.0%) | 127 (8.6%) | 196 (11.2%) | 0.013 |
OCCD test result . | All (n = 3223) . | Year 1 (n = 1478) . | Year 2 (n = 1745) . | Significance (P) . |
---|---|---|---|---|
TFF3 negative | 1031 (32.0%) | 398 (26.9%) | 633 (36.3%) | <0.001 |
TFF3 positive | 1598 (49.6%) | 775 (52.5%) | 823 (47.2%) | 0.003 |
Atypia | 151 (4.7%) | 98 (6.6%) | 53 (3.0%) | <0.001 |
P53 | 120 (3.7%) | 80 (5.4%) | 40 (2.3%) | <0.001 |
Insufficient | 323 (10.0%) | 127 (8.6%) | 196 (11.2%) | 0.013 |
OCCD, esophageal cell collection device; TFF3, trefoil factor 3.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.